| Veröffentlichte Version Download ( PDF | 11MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
Potent and Selective Caspase-2 Inhibitors: Biological Profiling, Structural Characterization, and Challenges of Molecular Instability
Artikel
Forster, Lisa
, Vallaster, Bernadette, Hubmann, Alexander, Bresinsky, Merlin Niklas
, Fuller, Jessica L.
, Shi, Ke, Lapcinski, Ian P., Liu, Peng, Yang, M., Strasser, Jessica M., Nelson, Kathryn M., John, Kristen, Mudaliar, Deepti, Wirth, Lukas, Daschner, Jonas, Pongratz, Herwig, Ashe, Karen H., Walters, Michael A.
und Pockes, Steffen
(2026)
Potent and Selective Caspase-2 Inhibitors: Biological Profiling, Structural Characterization, and Challenges of Molecular Instability.
Journal of Medicinal Chemistry.
DOI zum Zitieren dieses Dokuments: 10.5283/epub.83191
Zusammenfassung
Caspase-2 (Casp2) has emerged as a promising therapeutic target for neurodegenerative diseases due to its role in pathological tau processing. Here, we designed and synthesized a series of 48 novel peptidomimetic Casp2 inhibitors organized into distinct structural classes. Compounds were evaluated for Casp2 inhibition and selectivity against Casp1, 3, 4, 5, 6, 7, 8, 9, and 10. Inhibitors ...
Caspase-2 (Casp2) has emerged as a promising therapeutic target for neurodegenerative diseases due to its role in pathological tau processing. Here, we designed and synthesized a series of 48 novel peptidomimetic Casp2 inhibitors organized into distinct structural classes. Compounds were evaluated for Casp2 inhibition and selectivity against Casp1, 3, 4, 5, 6, 7, 8, 9, and 10. Inhibitors Idc(hE)G(Dab)D-CHO (32) and Idc(hE)G((S)-Me-THIQ)D-CHO (33) exhibited low nanomolar potency and ≥537-fold selectivity over Casp3. These unprecedented scaffold modifications are consistent with preferred steric arrangements between the P2 and P3 positions. Biochemical assays demonstrated the blockade of tau truncation and impaired the formation of toxic Δtau314. High-resolution crystal structures of compounds 2 and 33 bound to Casp2 revealed binding interactions consistent with the observed SAR. Although Idc(hE)V((S)-Me-THIQ)D-CHO (3, MUR-65) showed favorable ADME and pharmacokinetic properties, limited membrane permeability, insufficient blood−brain barrier penetration, and P5 indoline instability remain key challenges for further development.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Journal of Medicinal Chemistry | ||||
| Verlag | ACS | ||||
| Open Access Art | ACS Hybrid | ||||
| Datum | 7 November 2026 | ||||
| Veröffentlichungsdatum | 17 Nov 2026 10:22 | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie I (Prof. Elz) | ||||
| Projekte |
Gefördert von:
Deutsche Forschungsgemeinschaft (DFG)
(527849699)
| ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | Caspase-2; tau; selectivity; peptidomimetics; covalent reversible inhibitors; Alzheimer’s disease | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-831915 | ||||
| Dokumenten-ID | 83191 |
Downloadstatistik
Downloadstatistik